Clover Biopharma Advances Phase 2 Trial for RSV Combination Vaccines January 12, 2026 by Mathieu Maurice Clover Biopharmaceuticals, Ltd, a global biotechnology company with commercial-stage operations and a focus on developing innovative vaccines to protect lives and enhance public health worldwide, has announced the completion of …